Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|12|2959-2970

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.12, 2015-12, pp. : 2959-2970

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia

Acta Haematologica, Vol. 132, Iss. 1, 2014-02 ,pp. : 53-58

Karger

Access to resources Recommend Favorite

Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 255-262

Karger

Access to resources Recommend Favorite

RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow

By Xu Jingjing Zhou Peng Wang Wenjuan Sun Aining Guo Feng

Journal of Molecular Medicine, Vol. 92, Iss. 1, 2014-01 ,pp. : 77-92

Springer Publishing Company

Access to resources Recommend Favorite

Secondary Cutaneous Infiltration in B Cell Chronic Lymphocytic Leukemia

Acta Haematologica, Vol. 103, Iss. 2, 2000-05 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia

By Wiernik Peter H. Adiga Giridhar U.

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1987-1993

Informa Healthcare

Access to resources Recommend Favorite